American Society for Reconstructive Transplantation Virtual Meeting 2021
Format:4 videos + 1 pdf, size: 3.03 GB
Course Audience: cardiologist, primary care physican
Overview:
Course Objectives
Educational objectives will be met through a combination of paper presentations, lectures and symposia in plenary and specialty sessions allowing open discussion with the lecturers and paper presenters. The following objectives will be addressed during the Scientific Program, such that at the conclusion of this course the attendees should be able to:❖ Enumerate measures of success in reconstructive transplantation❖ Identify challenges and opportunities in funding of reconstructive transplantation❖ Compare similarities and differences between reconstructive and solid organ transplantation❖ Define psychosocial measures and outcomes in reconstructive transplantation❖ Identify the role of basic science in reconstructive transplantation research
Final Program 11-11-21 (PDF Format)
Part 1 (Video MP4 Format)Part 2 (Video MP4 Format)Part 3 (Video MP4 Format)Part 4 (Video MP4 Format)
* Detail:
7:00 am – 7:10 am Welcome & Introductions Gerald Brandacher, MD, Johns Hopkins University
Plenary Session I – Entering the Next Phase in VCA
7:10 am – 7:30 am Will Time Still Matter? Advances in Organ and Tissue Preservation Korkut Uygun, PhD, Massachusetts General Hospital7:30 am – 7:50 am How Do You Keep a Transplant Patient Safe in the Midst of a Pandemic? Suzanne V. McDiarmid, MD, University of California, Los Angeles7:50 am – 8:10 am The Immunologically Challenging Patient: Novel Therapies for Antibody Mediated Rejection Bruce Gelb, MD, NYU Langone Health8:10 am – 8:30 am Enhancing Functional Outcomes after VCA: PEG Fusion and New Strategies in Nerve Regeneration Jaimie T. Shores, MD, Johns Hopkins University8:30 am – 8:50 am Questions & Discussion8:50 am – 9:10 am BREAKPlenary Session II – Clinical Speed Updates from VCA Centers
9:10 am – 1:00 pmLive Discussion: Hand and Upper Extremity L. Scott Levin, MD, University of Pennsylvania Scott M. Tintle, MD, Walter Reed National Military Medical CenterLive Discussion: Face Bohdan Pomahac, MD, Yale School of Medicine Bruce Gelb, MD, NYU Langone HealthLive Discussion: Uterus, Urogenital, Abdominal Wall, Trachea, and other VCAs Giuliano Testa, MD, Baylor Scott & White Health Richard J. Redett III, MD, Johns Hopkins University1:00 pm – 1:30 pm Lunch Break1:30 pm – 3:00 pm Oral Abstract Presentations & Discussion*See Oral Abstracts on Pages 9-153:00 pm – 3:20 pm BREAKPlenary Session III – What is Needed to Ensure Sustainability of the Field/What Does Sustainability of the Field Look Like?
3:20 pm – 3:30 pm How to Quantify Outcomes after VCA Christina Kaufman, PhD, University of Louisville3:30 pm – 3:40 pm How to Quantify Outcomes after VCA Sheila G. Jowsey-Gregoire, MD, Mayo Clinic3:40 pm – 3:55 pm Uterus Transplantation: Not the New Kid on the Block Anymore Giuliano Testa, MD, Baylor Scott & White Health3:55 pm – 4:10 pm A Roadmap for Collaboration and the Next Phase of VCA Scott M. Tintle, MD, Walter Reed National Military Medical Center4:20 pm – 4:30 pm Closing Remarks Gerald Brandacher, MD, Johns Hopkins University